BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Vetter Expands its Footprint in Asia Pacific Region

  Vetter announced the official opening of a new branch office in South Korea.

  November 9, 2017

   · 

  3 min read
• Business

  Median Technologies Appoints Dr. Peter Bannister as Chief Technology Officer

  As Chief Technology Officer, Dr. Bannister is responsible for leading the development and scientific research teams at Median and ensuring that Median’s products directly address the unmet healthcare needs identified by the company’s clinical end users.

  November 9, 2017

   · 

  4 min read
• Deals

  PharMerica Announces Approval of Merger by Stockholders

  The closing of the transaction remains subject to customary closing conditions.

  November 9, 2017

   · 

  5 min read
• Genetown

  Navitor Pharmaceuticals’ Scientific Founder Makes Seminal Discoveries Related to Role of Nutrient Sensors in mTOR Regulation and Activity

  Today, Dr. Sabatini published in the journal Science the discovery of a new nutrient sensor in the mTORC1 pathway, SAMTOR

  November 9, 2017

   · 

  5 min read
• Business

  Stericycle, Inc. Announces Partnership With National Safety Council for Opioid Crisis Campaign

  NSC has partnered with Stericycle, Inc. to launch a provocative nationwide campaign that will illustrate the faces behind the numbers, educate people on the scope of the problem and promote solutions to address the crisis.

  November 9, 2017

   · 

  3 min read
• Pharm Country

  NY-ESO Data Presented at the Connective Tissue Oncology Society (CTOS) Annual Meeting Confirm Potential of Adaptimmune’s SPEAR T-Cell Therapy

  The company released updated data from the ongoing pilot study of NY‑ESO SPEAR T-cells in synovial sarcoma, as well as an overview of study design for the ongoing NY-ESO SPEAR T-cell trial.

  November 9, 2017

   · 

  5 min read
• Business

  Avenue Therapeutics Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights

  As of September 30, 2017, Avenue’s cash and short-term investments (certificates of deposit) totaled $26.1 million compared to $0.2 million at December 31, 2016, an increase of $25.9 million year-to-date.

  November 9, 2017

   · 

  6 min read
• Business

  Atara Biotherapeutics Announces Third Quarter 2017 Financial Results and Recent Highlights

  Cash, cash equivalents and short-term investments as of September 30, 2017 totaled $200.2 million.

  November 9, 2017

   · 

  17 min read
• Business

  Corium to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, November 16, 2017

  Corium will host a conference call and live audio webcast at 5:00 p.m. Eastern time, 2:00 p.m. Pacific time to discuss its financial results and report on recent progress.

  November 9, 2017

   · 

  1 min read
• Business

  SQI Diagnostics to Announce Fourth Quarter and Fiscal 2017 Results

  President and CEO, Andrew Morris, along with Company management, will host a conference call on Friday, November 17, 2017 at 10:00 a.m. ET to review financial results and discuss business developments for the period.

  November 9, 2017

   · 

  2 min read